Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort
- 1 January 2011
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 49 (11) , 1907-1910
Abstract
Symmetric dimethylarginine (SDMA) is a by-product of protein methylation. Once released from proteins, SDMA is eliminated by the kidneys; consequently, plasma concentration has been suggested as a sensitive marker of renal function. Furthermore, recent work implicates SDMA in the pathogenesis of cardiovascular disease. To date, reference limits for SDMA plasma concentrations in healthy individuals are lacking. This study defined reference limits for plasma SDMA concentrations in 840 relatively healthy individuals of the Offspring Cohort from Framingham Heart Study (mean age 56 years, 61% women). Plasma SDMA concentrations were determined by LC-MS/MS using a stable isotope dilution assay. The median SDMA concentration in the reference sample was 0.37 μmol/L (Q1, Q3:0.32, 0.43 μmol/L) and the reference limits were 0.225 and 0.533 (2.5th and 97.5th percentile). In a multivariable regression model, serum creatinine, age and total homocysteine were positively associated with SDMA (p<0.001 for all), whereas the body mass index and diastolic blood pressure were inversely related to SDMA (p-values<0.01 and 0.03, respectively). This study reports plasma SDMA reference limits from the community-based Framingham Heart Study. Plasma SDMA concentration was related positively to advancing age, but inversely to renal function. These reference limits may allow the identification of individuals with raised plasma SDMA concentrations.Keywords
This publication has 17 references indexed in Scilit:
- The role of asymmetric and symmetric dimethylarginines in renal diseaseNature Reviews Nephrology, 2011
- Dimethylarginines: their vascular and metabolic roles in Africans and CaucasiansEuropean Journal of Endocrinology, 2010
- Symmetric dimethylarginine predicts all-cause mortality following ischemic strokeAtherosclerosis, 2010
- Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular RisksArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Asymmetric Dimethylarginine Reference Intervals Determined with Liquid Chromatography–Tandem Mass Spectrometry: Results from the Framingham Offspring CohortClinical Chemistry, 2009
- Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general populationAtherosclerosis, 2009
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Chapter 3 The Emerging Role of Symmetric Dimethylarginine in Vascular Disease2009
- Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytesNephrology Dialysis Transplantation, 2008
- Health‐associated reference values for arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) measured with high‐performance liquid chromatographyScandinavian Journal of Clinical and Laboratory Investigation, 2007